About Us | Cytogenomix® Malaysia - Leading Genetic Testing Laboratory
ISO 15189 Accredited

Cytogenomix®

Affordable Genomics For All — Advancing precision medicine through accessible, accurate, and actionable genetic insights.

50K+ Tests Completed
98% Accuracy Rate
500+ Partner Clinics
15+ Years Experience

Our Mission

Affordable Genomics for All

To democratize genomic medicine by making high-quality genetic testing accessible, affordable, and actionable for healthcare providers and patients worldwide. We believe that genomic insights should not be a luxury but a standard part of patient care.

Our Vision

Making Diagnosis Molecular

A world where genomic information is seamlessly integrated into routine healthcare, enabling personalized prevention, diagnosis, and treatment for every individual, regardless of geographic or economic barriers.

Our Story

Founded in 2022 by a team of geneticists, molecular pathologists, and technology innovators, Cytogenomix® began with a simple yet powerful idea: that the cost of genomic testing should never be a barrier to patient care.

What started as a small molecular diagnostic laboratory has grown into an ISO-accredited clinical genomics laboratory serving healthcare providers across Malaysia. Our journey has been driven by a relentless commitment to quality, innovation, and accessibility.

Today, we offer a comprehensive menu of genetic tests spanning heritable disease, oncology, reproductive health, pharmacogenomics, and more — all delivered with the speed, accuracy, and affordability that modern medicine demands.

"Our goal has always been to bridge the gap between cutting-edge genomic medicine and everyday clinical practice. We're proud to be trusted by hundreds of healthcare providers who rely on our tests to make informed decisions for their patients."

— Dr. Mohamed Saleem, Founder & Chief Scientific Officer
Cytogenomix Laboratory
Our state-of-the-art genomics laboratory in Penang, Malaysia

Our Core Values

The principles that guide everything we do

Excellence

We pursue the highest standards in every test we perform, every report we issue, and every interaction we have with our clients.

Accessibility

We believe genomic testing should be available to all who need it, which is why we've made affordability a cornerstone of our mission.

Innovation

We continuously invest in research and development to bring the latest genomic technologies to clinical practice.

Integrity

We operate with transparency, honesty, and ethical responsibility in all aspects of our work.

Collaboration

We work hand-in-hand with healthcare providers to ensure they have the support they need to deliver precision medicine.

Compassion

We never lose sight of the fact that behind every test is a patient and a family waiting for answers.

Leadership Team

Meet the experts driving Cytogenomix® forward

Dr. Mohamed Saleem

Dr. Mohamed Saleem

Founder & CEO

PhD in Medical Genetics with 15+ years of experience in molecular diagnostics. Previously led a leading molecular diagnostic company with special interest in reproductive medicine.

Dr. Mohamed Saleem

Professor Narazah

Director

MD, PhD with specialization in molecular pathology. Board-certified in Clinical Pathology and Molecular Genetic Pathology. Former director of Advanced Medical and Dental Institute, USM.

Scientific Advisory Board

Distinguished experts who guide our scientific direction

Dr. Mohamed Saleem

Dr. Mohamed Saleem

MSc, PhD
Putra University Malaysia
Prof Dr. Narazah

Prof Dr. Narazah

MD, PhD
Universiti Putra Malaysia
Dr. Mathew

Dr. Mathew Papachan

MD, FACMG
Lifeline Hospitals

Dr. Emmanuel Jairaj Moses

PhD
Univeriti Sains Malaysis

Our Journey

Key milestones in Cytogenomix® history

2021

Company Founded

Cytogenomix® established as a Molecular Diagnostic Service Provider in Penang, Malaysia.

2022

Launched NIPT

Non-invasive prenatal testing services established, followed by comprehensive reproductive genetics menu.

2022

ISO 15189 Accreditation

Achieved ISO 15189 accreditation. Active participant in CAP and GenQA proficiency testing programs.

2023

Expanded Test Menu

Launched comprehensive Reproductive Genetics, Neurogenetics and Immunogenetics panels.

2023

National Expansion

Expanded services nationwide, serving healthcare providers across all Malaysian states.

2024

Launched CMA

Introduced Chromosomal Microarray Analysis to complement cytogenetics services.

ISO 15189 Medical Laboratories
CAP Proficiency Testing
GenQA UK NEQAS

Active participant in international proficiency testing programs, ensuring the highest quality standards.

Ready to partner with us?

Join hundreds of healthcare providers across Malaysia who trust Cytogenomix® for their genetic testing needs.

Chat with us